N,N'-di-p-tolyl-octanediamide | 168832-50-6

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: N,N'-di-p-tolyl-octanediamide
• 英文别名: N,N'-Di-p-tolyl-octandiamid；Korksaeure-di-p-toluidid；N.N'-Di-p-tolyl-suberamid；N,N'-bis(4-methylphenyl)octanediamide
• CAS: 168832-50-6
• 化学式: C₂₂H₂₈N₂O₂
• 分子量: 352.477
• InChiKey: FUJTUUTZOJANCC-UHFFFAOYSA-N

物化性质

• 熔点：
  217-218 °C
• 沸点：
  600.6±43.0 °C(Predicted)
• 密度：
  1.118±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  4.4
• 重原子数：
  26
• 可旋转键数：
  9
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.36
• 拓扑面积：
  58.2
• 氢给体数：
  2
• 氢受体数：
  2

反应信息

• 作为产物：
  描述：

  辛二酸 在 氯化亚砜 作用下， 以 吡啶 为溶剂， 反应 28.0h， 生成 N,N'-di-p-tolyl-octanediamide
  参考文献：
  名称：

  Synthesis of N,N’-Diarylalkanediamides and Their Antimycobacterial and Antialgal Activity

  摘要：

  合成了一组N,N'-二芳基烷二胺。对这些化合物进行了抗分枝杆菌和抗藻类活性的测试。N,N'-二芳基烷二胺的抗分枝杆菌活性取决于相应酸的脂溶性。抗分枝杆菌活性物质仅在N,N'-二芳基乙二胺和N,N'-二芳基丁二胺系列中被发现。其他化合物（戊烷、己烷、辛烷和壬烷二胺的衍生物）对各种分枝杆菌株无活性。这些化合物抑制了小球藻（Chlorella vulgaris）的生长和叶绿素的产生。它们相对较低的抗藻类活性可能与其疏水性溶解度降低有关，因此抑制剂通过类囊体膜的亲水区域的通透性受到限制。

  DOI：

  10.3390/50500714

文献信息

• Biological and Biophysical Properties of the Histone Deacetylase Inhibitor Suberoylanilide Hydroxamic Acid Are Affected by the Presence of Short Alkyl Groups on the Phenyl Ring
  作者：Frédérik Oger、Aurélien Lecorgne、Elisa Sala、Vanessa Nardese、Florence Demay、Soizic Chevance、Danielle C. Desravines、Nataliia Aleksandrova、Rémy Le Guével、Simone Lorenzi、Andrea R. Beccari、Peter Barath、Darren J. Hart、Arnaud Bondon、Daniele Carettoni、Gérard Simonneaux、Gilles Salbert

  DOI：10.1021/jm901561u

  日期：2010.3.11

  HDAC inhibitor (HDACi) is used in therapy: suberoylanilide hydroxamic acid (SAHA). Here, we describe the synthesis and biological evaluation of a new series of compounds derived from SAHA by substituting short alkyl chains at various positions of the phenyl ring. Such modifications induced variable effects ranging from partial loss of activity to increased potency. Through molecular modeling, we describe

  组蛋白脱乙酰基酶（HDACs）的抑制导致肿瘤细胞系的生长停滞，分化或凋亡，这表明HDACs是癌症治疗的有希望的靶标。目前，只有一种HDAC抑制剂（HDACi）用于治疗：磺酰苯胺异羟肟酸（SAHA）。在这里，我们描述了由SAHA衍生的一系列新化合物的合成和生物学评估，方法是通过在苯环的各个位置上取代短烷基链。这种修饰引起可变的作用，其范围从活性的部分丧失到效力的增加。通过分子建模，我们描述了HDAC7脯氨酸809（仅在第2类酶中严格保守的残基）与HDACi的酰胺基团之间的可能相互作用，而核磁共振实验表明，二甲基m-取代可以使抑制剂稳定在活性位点。我们的数据提供了有关HDACi的结构活性关系的新颖信息，并提出了开发第二代SAHA样分子的新方法。
• Unusual clinical manifestation of pheochromocytoma in a MEN2A patient
  作者：M. Guerrieri、S. Filipponi、G. Arnaldi、M. Giovagnetti、E. Lezoche、F. Mantero、A. Taccaliti

  DOI：10.1007/bf03343961

  日期：2002.1

  A case of unusual clinical manifestation of pheochromocytoma in a type 2A multiple endocrine neoplasia (MEN2A) patient is presented. A 27-year-old man affected by MEN2A syndrome; complaining of anxiety and depression, was admitted in our Division. Past medical history included a total thyroidectomy for medullary carcinoma in 1985, and left adrenalectomy for pheochromocytoma in 1994. Blood pressure was 130/85 mmHg without orthostatic hypotension and pulse rate was 72 beats/min. Laboratory data revealed thyroid hormones and carcinoembryonic antigen (CEA) in the normal range and high basal serum calcitonin levels (158 pg/ml). Plasma catecholamines and vanillymandelic acid resulted in normal levels but epinephrine/norepinephrine ratio was elevated (0.65). The glucagon stimulation test showed positive clinical and biochemical response. Magnetic resonance imaging (MRI) and meta-iodobenzylguanidine (MIBG) scintiscan confirmed the presence of bilateral adrenal masses. Bilateral adrenalectomy by laparoscopic anterior approach was performed. Histology was consistent with adrenal pheochromocytomas. After surgical approach, psychiatric findings disappeared and did not recur at follow-up in spite of no medication for two years. In conclusion, bilateral pheochromocytoma is more frequent in MEN2A syndrome and probably understimated if the follow-up is not prolonged. In these cases clinical features are often aspecific and basal hormonal data may be normal in a great number of patients. Therefore long-term observation is justified in these patients. Pheochromocytoma was described as the "great mimic" for the numerous subjective manifestations. Differential diagnosis among typical features of neuropsychiatric disorders and pheochromocytoma must be considered. (C) 2002, Editrice Kurtis.
• Blaise; Koehler, Bulletin de la Societe Chimique de France, 1909, vol. <4>5, p. 690
  作者：Blaise、Koehler

  DOI：——

  日期：——
• Synthesis of N,N’-Diarylalkanediamides and Their Antimycobacterial and Antialgal Activity
  作者：Lenka Kubicova、Karel Waisser、Jiri Kunes、Katarina Kralova、Zelmira Odlerova、Milan Slosarek、Jiri Janota、Zbynek Svoboda

  DOI：10.3390/50500714

  日期：——

  A set of N,N'-diarylalkanediamides was synthesized. The compounds were tested for their antimycobacterial and antialgal activity. The antimycobacterial activity of N,N'-diarylalkanediamides depends on the lipophilicity of the respective acid. Antimycobacterially active substances were found only in the series of N,N'-diarylethanediamides and N,N'-diarylbutanediamides. Other compounds (derivatives of pentane-, hexane-, octane- and nonanediamide) were inactive against various strains of mycobacteria. The compounds inhibited growth and chlorophyll production in Chlorella vulgaris. Their relatively low antialgal activity is probably connected with their lowered aqueous solubility, and hence by a restricted passage of the inhibitor through the hydrophilic regions of thylakoid membranes.

  合成了一组N,N'-二芳基烷二胺。对这些化合物进行了抗分枝杆菌和抗藻类活性的测试。N,N'-二芳基烷二胺的抗分枝杆菌活性取决于相应酸的脂溶性。抗分枝杆菌活性物质仅在N,N'-二芳基乙二胺和N,N'-二芳基丁二胺系列中被发现。其他化合物（戊烷、己烷、辛烷和壬烷二胺的衍生物）对各种分枝杆菌株无活性。这些化合物抑制了小球藻（Chlorella vulgaris）的生长和叶绿素的产生。它们相对较低的抗藻类活性可能与其疏水性溶解度降低有关，因此抑制剂通过类囊体膜的亲水区域的通透性受到限制。